Targeting Nonhomologous End-Joining Through Epidermal Growth Factor Receptor Inhibition: Rationale and Strategies for Radiosensitization
- 31 October 2010
- journal article
- research article
- Published by Elsevier BV in Seminars in Radiation Oncology
- Vol. 20 (4), 250-257
- https://doi.org/10.1016/j.semradonc.2010.05.002
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeatsNature, 2009
- Distinct roles of ATR and DNA‐PKcs in triggering DNA damage responses in ATM‐deficient cellsEMBO Reports, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joiningBiochemical Journal, 2009
- EGFR inhibition in the treatment of non‐small cell lung cancerDrug Development Research, 2008
- ATR: an essential regulator of genome integrityNature Reviews Molecular Cell Biology, 2008
- p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PKProceedings of the National Academy of Sciences of the United States of America, 2008
- The HER family and cancer: emerging molecular mechanisms and therapeutic targetsTrends in Molecular Medicine, 2007
- Cellular responses to EGFR inhibitors and their relevance to cancer therapyCancer Letters, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007